Form 4 for CVS CVS Health
Accepted 2021-10-28 00:00:00 ET · period of report 2021-10-26 · accession 0001127602-21-027755 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-28 | 2021-10-26 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $54.19 | +80.8K | 221.0K | +58% | +$4.38M |
| DM | 2021-10-28 | 2021-10-26 | CVS | Brennan Troyen A | EVP, Chief Medical Off | S - Sale+OE | $88.00 | -82.8K | 219.0K | -27% | -$7.28M |
| D | 2021-10-28 | 2021-10-26 | CVS | Brennan Troyen A | EVP, Chief Medical Off | M - OptEx | $0.00 | -80.8K | 80.8K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-26 | M | A | 80,802 | $54.19 | 221,003.06 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-26 | S | D | 80,802 | $88.00 | 138,246.06 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-26 | S | D | 1,955 | $88.00 | 219,048.06 | D | — | — | |
| 4 | Derivative | Stock Option | 2021-10-26 | M | D | 80,802 | $0.00 | 80,803 | D | $54.19 · 2020-04-01 to 2029-04-01 | 80,802 Common Stock | (F2) Option became exercisable in four equal annual installments, commencing 4/1/2020. |